Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000875320-23-000050
Filing Date
2023-12-06
Accepted
2023-12-06 16:03:51
Documents
3
Period of Report
2023-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1701896619.html 3  
1 FORM 3 wk-form3_1701896619.xml 3 1650
2 EX-24 section16poant_1.htm EX-24 4016
3 GRAPHIC section16poant_1001.jpg GRAPHIC 240453
  Complete submission text file 0000875320-23-000050.txt   338298
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036
Business Address
Thornberry Nancy (Reporting) CIK: 0001797826 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 231469615